A Randomized, Double-blind, Placebo-controlled, Two-cohort, Three-way Crossover Clinical Trial to Evaluate the Pharmacodynamic Effect of Different Doses of TPN171H Tablets in Mild to Moderate Male Erectile Dysfunction
Latest Information Update: 28 Feb 2023
At a glance
- Drugs Simmerafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors Vigonvita Life Sciences
Most Recent Events
- 13 Feb 2023 Status changed from recruiting to completed.
- 30 Jan 2023 Planned End Date changed from 30 Mar 2023 to 28 Feb 2023.
- 15 Aug 2022 Status changed from not yet recruiting to recruiting.